New research shows for the first time why the antiviral drug remdesivir works against some viruses but not others—a finding that improves our understanding of how antiviral drugs interact with viruses at a molecular level, ...
Jan 13, 2022
0
19
Biogen is slashing the price of its Alzheimer's treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.
Dec 20, 2021
0
5
The federal Food and Drug Administration has approved an incisionless form of brain surgery to treat advanced Parkinson's disease after successful testing at the University of Virginia School of Medicine and other sites.
Nov 17, 2021
0
13
The U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer's disease, has drawn decidedly mixed reviews.
Jun 21, 2021
0
2
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer's disease. But approval of the drug has provoked mixed reactions from the scientific ...
Jun 16, 2021
0
5
(HealthDay)—A new and expensive antifungal drug to treat vaginal yeast infections was approved by the U.S. Food and Drug Administration this week, but critics say it is not needed.
Jun 4, 2021
0
4
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being ...
May 6, 2021
0
12
Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.
Apr 25, 2021
0
60
(HealthDay)—Moderna has been authorized to put 50 percent more COVID-19 vaccine into its vials, the U.S. Food and Drug Administration said Thursday.
Apr 5, 2021
0
3
For parents with questions about COVID-19 vaccines and children, Johns Hopkins Medicine experts offer answers.
Feb 15, 2021
0
2
